Jaguar Health Inc (NASDAQ:JAGX) was the recipient of a large increase in short interest in the month of January. As of January 31st, there was short interest totalling 4,353,797 shares, an increase of 32.8% from the January 12th total of 3,277,733 shares. Based on an average trading volume of 5,722,928 shares, the days-to-cover ratio is currently 0.8 days. Approximately 10.6% of the company’s shares are sold short.

Shares of Jaguar Health (JAGX) opened at $0.14 on Wednesday. The company has a debt-to-equity ratio of 0.35, a current ratio of 0.26 and a quick ratio of 0.15. Jaguar Health has a 12 month low of $0.10 and a 12 month high of $1.52. The company has a market cap of $15.37 and a price-to-earnings ratio of -0.21.

Jaguar Health (NASDAQ:JAGX) last posted its quarterly earnings data on Monday, November 20th. The biotechnology company reported $0.13 EPS for the quarter. Jaguar Health had a negative net margin of 190.94% and a negative return on equity of 17.50%.

Separately, ValuEngine upgraded shares of Jaguar Health from a “strong sell” rating to a “sell” rating in a research report on Friday, February 2nd.

ILLEGAL ACTIVITY WARNING: This piece was originally posted by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are reading this piece on another site, it was stolen and republished in violation of international trademark and copyright law. The original version of this piece can be viewed at

About Jaguar Health

Jaguar Health, Inc, formerly Jaguar Animal Health, Inc, is a natural-products pharmaceuticals company. The Company is focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human prescription use and animals on a global basis. The Company, through its subsidiary Napo Pharmaceuticals, Inc, is focused on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas.

Receive News & Ratings for Jaguar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Health and related companies with's FREE daily email newsletter.